S Perez-Buira, M Barrachina, A Rodriguez, J L Albasanz, M Martín, I Ferrer
Index: Neurosci. Lett. 423(3) , 194-9, (2007)
Full Text: HTML
Expression of adenosine receptors of the A1, A2A and A2B type has been examined in the post-mortem frontal cortex and hippocampus in argyrophilic grain disease (AGD), a tauopathy affecting the hippocampus but usually not the frontal cortex, in an attempt to learn about the modulation of the adenosine pathway in this disorder. Significant increased levels of A1, but not of A2A and A2B, have been observed in AGD in the hippocampus but not in the frontal cortex, when compared with age-matched controls. This is accompanied by increased levels of adenylyl cyclase (AC), an effector of A1, and by increased (although not significant) percentage of inhibition of forskolin-stimulated AC by the A1 agonist cyclohexyladenosine in the hippocampus in AGD. These findings indicate sensitization of A1/AC in the hippocampus in AGD, and support a putative activation of the A1/AC pathway that may facilitate protection of this preferentially involved region in AGD.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
D-Cyclohexylalanine
CAS:58717-02-5 |
C9H17NO2 |
Experimental evaluation of CH-π interactions in a protein co...
2012-05-07 [Chemistry 18(19) , 5832-6, (2012)] |
Sequential and specific exchange of multiple coiled-coil com...
2003-10-29 [J. Am. Chem. Soc. 125(43) , 13046-51, (2003)] |
Mapping the ligand-binding site on the C5a receptor: arginin...
2001-11-20 [Biochemistry 40(46) , 14047-52, (2001)] |
Synthesis and characterization of more potent analogues of h...
1998-09-29 [Biochemistry 37(39) , 13507-15, (1998)] |
Up-regulation of adenosine A1 receptor binding in pentylenet...
2005-01-25 [Brain Res. 1032(1-2) , 94-103, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved